Table 2 Disease areas in which PE activities were reported
From: Practices of patient engagement in drug development: a systematic scoping review
Disease areas | Nr. of publications |
|---|---|
Non-communicable diseases | |
 Cancer | 30 |
 Autoimmune diseases | 16 |
 Rare diseases | 10 |
 Neurological and psychiatric conditions | 8 |
 Lung and esophageal disorders | 7 |
 Endocrine diseases | 6 |
 Cardiovascular diseases (CVD) | 4 |
 Chronic kidney disease (CKD) | 1 |
 Non-specific low back pain (NSLBP) | 1 |
Communicable diseases | |
 Infectious diseases | 7 |
 HIV/AIDS | 4 |
 Hepatitis C Virus (HCV) | 2 |
 Severe or critical COVID-19 pneumonia | 1 |